Susan Molineaux

CIK 1553389 · PRESIDENT & CEO · last filed 2026-05-26

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$999.3K

Companies

5

Total Filings

69

Lifetime Open-Market Net

$198.1K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GERN Director 130,527 $1.15 $150.1K -$86.8K 39 2026-05-26
Repare Therapeutics Inc. (RPTX) Delisted Director $2.65 $0 2 2024-06-20
Cyteir Therapeutics, Inc. (CYT) Delisted Director $3.02 $0 2 2023-02-07
CALA PRESIDENT & CEO 32,583 $0.00 $10 $284.9K 19 2023-01-25
TBPH Director 51,034 $16.64 $849.2K $0 7 2021-04-29

Recent Filings · Page 3 of 7

69 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-06-09 GERN Grant (A) $0 EDGAR
2020-04-30 TBPH Grant (A) +6,635 $0 EDGAR
2020-01-22 CALA Grant (A) $0 EDGAR
2019-06-27 CALA Buy (P) +51,600 $200.2K EDGAR
2019-06-07 GERN Grant (A) $0 EDGAR
2019-05-02 TBPH Grant (A) +8,385 $0 EDGAR
2019-02-11 CALA Gift (G) −12,986 $0 EDGAR
2019-01-14 CALA Grant (A) $0 EDGAR
2019-01-02 GERN Grant (A) +13,125 $0 EDGAR
2018-11-16 CALA Gift (G) −6,476 $0 EDGAR
Showing 2130 of 69
Page 3 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.